Search

Your search keyword '"Matti A Rookus"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Matti A Rookus" Remove constraint Author: "Matti A Rookus"
159 results on '"Matti A Rookus"'

Search Results

1. Associations of night shift work with weight gain among female nurses in The Netherlands: results of a prospective cohort study

2. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

3. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.

4. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

5. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.

6. Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.

7. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

8. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.

9. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers

10. Table S7 from A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

11. Supplementary Fig. S5 from Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

12. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

13. Supplementary Table 1 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

14. Supplementary Table S2 from Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

15. Data from Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

16. Online Supplementary Materials from A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

17. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

18. Data from A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

19. Data from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

20. Supplementary Tables 1 through 5 from Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands

22. Data from Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands

23. Supplementary Table S1 from Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation Carriers

25. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

26. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

27. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

28. Long-term morbidity and health after early menopause due to oophorectomy in women at increased risk of ovarian cancer: Protocol for a nationwide cross-sectional study with prospective follow-up (HARMOny Study)

29. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

30. Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study) (Preprint)

31. Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations

32. Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

33. Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

34. Abstract P3-10-01: Tamoxifen and contralateral breast cancer (CBC) risk for BRCA1 and BRCA2 mutation carriers: An updated analysis of data from the Kathleen Cuningham Foundation consortium for research into familial breast cancer, the International BRCA1 and BRCA2 Carrier cohort study and the breast cancer family registry

35. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

36. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

37. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

38. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

39. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

40. Association of Genomic Domains in

41. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for

42. Germline

43. Abstract P5-08-09: Use of oral contraceptives and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: An international prospective cohort study; for the studies of EMBRACE, GENEPSO, HEBON, kConFab and BCFR

44. Toward the optimal strategy for sustained weight loss in overweight cancer survivors: a systematic review of the literature

45. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

46. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

47. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With

48. Diet, Physical Activity, and Daylight Exposure Patterns in Night-Shift Workers and Day Workers

49. Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

50. The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?

Catalog

Books, media, physical & digital resources